The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Open accessAbstract
The Eph receptor tyrosine kinases and their ephrin ligands have intriguing expression patterns in cancer cells and tumour blood vessels, which suggest important roles for their bidirectional signals in many aspects of cancer development and progression. Eph gene mutations probably also contribute to cancer pathogenesis. Eph receptors and ephrins have been shown to affect the growth, migration and invasion of cancer cells in culture as well as tumour growth, invasiveness, angiogenesis and metastasis in vivo. However, Eph signalling activities in cancer seem to be complex, and are characterized by puzzling dichotomies. Nevertheless, the Eph receptors are promising new therapeutic targets in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207247 · Cited by 211
RetractedThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Eph-Ephrin Bidirectional Signaling in Physiology and Disease
Pasquale, E. B. (2008) · Cell · doi:10.1016/j.cell.2008.03.011 · Cited by 1,252
Self-citationBatlle, E., Henderson, J. T., Beghtel, H., van den Born, M. M. W., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01015-2 · Cited by 1,120
Eph receptor signalling casts a wide net on cell behaviour
Pasquale, E. B. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1662 · Cited by 1,017
Self-citationFasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M. C., & Martelli, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800731200 · Cited by 912
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675
Cell Signaling in Space and Time: Where Proteins Come Together and When They’re Apart
Scott, J. D., & Pawson, T. (2009) · Science · doi:10.1126/science.1175668 · Cited by 645
Miao, H., Li, D.-Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., Basilion, J. P., Sedor, J., Wu, J., Danielpour, D., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.009 · Cited by 533
Regulated Cleavage of a Contact-Mediated Axon Repellent
Hattori, M., Osterfield, M., & Flanagan, J. G. (2000) · Science · doi:10.1126/science.289.5483.1360 · Cited by 518
Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer
Davies, H., Hunter, C., Smith, R., Stephens, P., Greenman, C., Bignell, G., Teague, J., Butler, A., Edkins, S., Stevens, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1855 · Cited by 469
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Zelinski, D. P., Zantek, N. D., Stewart, J. C., Irizarry, A. R., & Kinch, M. S. (2001) · PubMed · Cited by 463
Identification and classification of p53-regulated genes
Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., & Vogelstein, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14517 · Cited by 452
Ephrin-B2 Controls Cell Motility and Adhesion during Blood-Vessel-Wall Assembly
Foo, S. S., Turner, C. J., Adams, S., Compagni, A., Aubyn, D., Kogata, N., Lindblom, P., Shani, M., Zicha, D., & Adams, R. H. (2006) · Cell · doi:10.1016/j.cell.2005.10.034 · Cited by 441
A Novel Putative Tyrosine Kinase Receptor Encoded by the eph Gene
Hirai, H., Maru, Y., Hagiwara, K., Nishida, J., & Takaku, F. (1987) · Science · doi:10.1126/science.2825356 · Cited by 441
Bidirectional modulation of synaptic functions by Eph/ephrin signaling
Klein, R. (2009) · Nature Neuroscience · doi:10.1038/nn.2231 · Cited by 423
EphB receptor activity suppresses colorectal cancer progression
Batlle, E., Bacani, J., Begthel, H., Jonkeer, S., Gregorieff, A., van de Born, M., Malats, N., Sancho, E., Boon, E., Pawson, T., et al. (2005) · Nature · doi:10.1038/nature03626 · Cited by 413
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., & Pasquale, E. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204004 · Cited by 380
Self-citationRole of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis
Pandey, A., Shao, H., Marks, R. M., Polverini, P. J., & Dixit, V. M. (1995) · Science · doi:10.1126/science.7536959 · Cited by 363
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
Miao, H., Wei, B.-R., Peehl, D. M., Li, Q., Alexandrou, T., Schelling, J. R., Rhim, J. S., Sedor, J. R., Burnett, E., & Wang, B. (2001) · Nature Cell Biology · doi:10.1038/35074604 · Cited by 358
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
Program, N. C. S., Prickett, T. D., Agrawal, N. S., Wei, X., Yates, K. E., Lin, J. C., Wunderlich, J. R., Cronin, J. C., Cruz, P., Rosenberg, S. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.438 · Cited by 352
Herbert, S. P., Huisken, J., Kim, T. N., Feldman, M. E., Houseman, B. T., Wang, R. A., Shokat, K. M., & Stainier, D. Y. R. (2009) · Science · doi:10.1126/science.1178577 · Cited by 348
Huang, F., Reeves, K., Han, X., Fairchild, C., Platero, S., Wong, T. W., Lee, F., Shaw, P., & Clark, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3633 · Cited by 344 · cited 1×
“Furthermore, EPHA2 seems to be preferentially expressed in malignant breast and prostate cancers with a basal phenotype”
BackgroundThe role of ephrins and Eph receptors in cancer
Surawska, H., Ma, P. C., & Salgia, R. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.09.002 · Cited by 341
Shekhar, M. P. V., Werdell, J., Santner, S. J., Pauley, R. J., & Tait, L. R. (2001) · PubMed · Cited by 327
Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and Cancers
Hafner, C., Schmitz, G., Meyer, S., Bataille, F., Hau, P., Langmann, T., Dietmaier, W., Landthaler, M., & Vogt, T. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026849 · Cited by 323
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Brantley, D. M., Cheng, N., Thompson, E. J., Lin, Q., Brekken, R. A., Thorpe, P. E., Muraoka, R. S., Cerretti, D. P., Pozzi, A., Jackson, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205679 · Cited by 316
Eph/ephrin signaling: networks
Arvanitis, D., & Davy, A. (2008) · Genes & Development · doi:10.1101/gad.1630408 · Cited by 303
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Wykosky, J., & Debinski, W. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0244 · Cited by 300
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl–Crk pathway
Noren, N. K., Foos, G., Hauser, C. A., & Pasquale, E. B. (2006) · Nature Cell Biology · doi:10.1038/ncb1438 · Cited by 288
Self-citationBrantley-Sieders, D. M., Zhuang, G., Hicks, D., Fang, W. B., Hwang, Y., Cates, J. M. M., Coffman, K., Jackson, D., Bruckheimer, E., Muraoka-Cook, R. S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33154 · Cited by 278
EphB–ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells
Cortina, C., Palomo-Ponce, S., Iglesias, M., Fernández-Masip, J. L., Vivancos, A., Whissell, G., Humà, M., Peiró, N., Gallego, L., Jonkheer, S., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.11 · Cited by 269
A conditional feedback loop regulates Ras activity through EphA2
Macrae, M., Neve, R. M., Rodriguez-Viciana, P., Haqq, C., Yeh, J., Chen, C., Gray, J. W., & McCormick, F. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.005 · Cited by 260
Regulation of Angiogenesis by Eph–Ephrin Interactions
Kuijper, S., Turner, C. J., & Adams, R. H. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.03.003 · Cited by 257
Cheng, N., Brantley, D. M., Liu, H., Lin, Q., Enriquez, M., Gale, N., Yancopoulos, G. D., Cerretti, D. P., Daniel, T. O., & Chen, J. (2002) · PubMed · Cited by 255
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.
Zantek, N. D., Azimi, M., Fedor‐Chaiken, M., Wang, B., Brackenbury, R. W., & Kinch, M. S. (1999) · PubMed · Cited by 249
Tsc2-Rheb signaling regulates EphA-mediated axon guidance
Nie, D., Di Nardo, A., Han, J. M., Baharanyi, H., Kramvis, I., Huynh, T., Dabora, S., Codeluppi, S., Pandolfi, P. P., Pasquale, E. B., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2477 · Cited by 248
Self-citationB61 is a ligand for the ECK receptor protein-tyrosine kinase
Bartley, T. D., Hunt, R. W., Welcher, A. A., Boyle, W. J., Parker, V. P., Lindberg, R. A., Lu, H. S., Colombero, A. M., Elliott, R. L., Guthrie, B. A., et al. (1994) · Nature · doi:10.1038/368558a0 · Cited by 246
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth
Noren, N. K., Lu, M., Freeman, A. L., Koolpe, M., & Pasquale, E. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401381101 · Cited by 245
Self-citationTsuda, H., Han, S. M., Yang, Y., Tong, C., Lin, Y. Q., Mohan, K., Haueter, C., Zoghbi, A., Harati, Y., Kwan, J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.039 · Cited by 242
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype
Almog, N., Ma, L., Raychowdhury, R., Schwager, C., Erber, R., Short, S., Hlatky, L., Vajkoczy, P., Huber, P. E., Folkman, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2590 · Cited by 240
Chromosomal Abnormalities in Cancer
Fröhling, S., & Döhner, H. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0803109 · Cited by 229
Jørgensen, C., Sherman, A., Chen, G. I., Pasculescu, A., Poliakov, A., Hsiung, M., Larsen, B., Wilkinson, D. G., Linding, R., & Pawson, T. (2009) · Science · doi:10.1126/science.1176615 · Cited by 226
An Ephrin Mimetic Peptide That Selectively Targets the EphA2 Receptor
Koolpe, M., Dail, M., & Pasquale, E. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208495200 · Cited by 211
Self-citationElevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
Zhuang, G., Brantley-Sieders, D. M., Vaught, D., Yu, J., Xie, L., Wells, S., Jackson, D., Muraoka-Cook, R., Arteaga, C., & Chen, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1845 · Cited by 208
p75NTR Mediates Ephrin-A Reverse Signaling Required for Axon Repulsion and Mapping
Lim, Y.-S., McLaughlin, T., Sung, T.-C., Santiago, A., Lee, K.-F., & O'Leary, D. D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.032 · Cited by 202
Molecular Cancer BioMed Central Molecular 12002, Cancer
Lynch, C. A., Tycko, B., Bestor, T. H., & Walsh, C. P. (2002) · Molecular Cancer · doi:10.1186/1476-4598-1-2 · Cited by 202
Scarberry, K. E., Dickerson, E. B., McDonald, J. F., & Zhang, Z. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801969b · Cited by 201
Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
Carles‐Kinch, K., Kilpatrick, K. E., Stewart, J. C., & Kinch, M. S. (2002) · PubMed · Cited by 195
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer
Huusko, P., Ponciano-Jackson, D., Wolf, M., Kiefer, J. A., Azorsa, D. O., Tuzmen, S., Weaver, D., Robbins, C., Moses, T., Allinen, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1408 · Cited by 194
Eph receptor–ephrin bidirectional signals that target Ras and Rho proteins
Noren, N. K., & Pasquale, E. B. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.10.006 · Cited by 194
Self-citationReceptor Tyrosine Kinase EphB4 Is a Survival Factor in Breast Cancer
Kumar, S. R., Singh, J., Xia, G., Krasnoperov, V., Hassanieh, L., Ley, E. J., Scehnet, J., Kumar, N. G., Hawes, D., Press, M. F., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050889 · Cited by 191
Pulkkinen, K., Malm, T., Turunen, M., Koistinaho, J., & Ylä-Herttuala, S. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.048 · Cited by 187
An efficient rapid system for profiling the cellular activities of molecular libraries
Melnick, J. S., Janes, J., Kim, S., Chang, J. Y., Sipes, D. G., Gunderson, D., Jarnes, L., Matzen, J. T., Garcia, M. E., Hood, T. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511292103 · Cited by 186
EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics
Ireton, R., & Chen, J. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053765780 · Cited by 178
Genander, M., Halford, M. M., Xu, N.-J., Eriksson, M., Yu, Z., Qiu, Z., Martling, A., Greicius, G., Thakar, S., Catchpole, T., et al. (2009) · Cell · doi:10.1016/j.cell.2009.08.048 · Cited by 178
Fluid shear stress induces arterial differentiation of endothelial progenitor cells
Obi, S., Yamamoto, K., Shimizu, N., Kumagaya, S., Masumura, T., Sokabe, T., Asahara, T., & Ando, J. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00197.2008 · Cited by 178
van Doorn, R., Dijkman, R., Vermeer, M. H., Out-Luiting, J. J., van der Raaij-Helmer, E. M. H., Willemze, R., & Tensen, C. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1253 · Cited by 168
Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis
Laiho, P., Kokko, A., Vanharanta, S., Salovaara, R., Sammalkorpi, H., Järvinen, H., Mecklin, J.-P., Karttunen, T. J., Tuppurainen, K., Davalos, V, et al. (2007) · Oncogene · doi:10.1038/sj.onc.1209778 · Cited by 165
Kertesz, N., Krasnoperov, V., Reddy, R., Leshanski, L., Kumar, S. R., Zozulya, S., & Gill, P. S. (2006) · Blood · doi:10.1182/blood-2005-04-1655 · Cited by 164
EphB2/R-Ras Signaling Regulates Glioma Cell Adhesion, Growth, and Invasion
Nakada, M., Niska, J. A., Tran, N. L., McDonough, W. S., & Berens, M. E. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62998-7 · Cited by 164
Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression
HEROULT, M., SCHAFFNER, F., & AUGUSTIN, H. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.028 · Cited by 160
Antiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist
Dobrzanski, P., Hunter, K., Jones-Bolin, S., Chang, H., Robinson, C., Pritchard, S., Zhao, H., & Ruggeri, B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3430-2 · Cited by 160
Georgakopoulos, A., Litterst, C., Ghersi, E., Baki, L., Xu, C., Serban, G., & Robakis, N. K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601031 · Cited by 160
EPHA2 Is Associated with Age-Related Cortical Cataract in Mice and Humans
Jun, G., Guo, H., Klein, B. E. K., Klein, R., Wang, J. J., Mitchell, P., Miao, H., Lee, K. E., Joshi, T., Buck, M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000584 · Cited by 158
Chang, Q., Jorgensen, C., Pawson, T., & Hedley, D. W. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604676 · Cited by 158
Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning
Xu, N.-J., & Henkemeyer, M. (2009) · Nature Neuroscience · doi:10.1038/nn.2254 · Cited by 158
EphB4 controls blood vascular morphogenesis during postnatal angiogenesis
Erber, R., Eichelsbacher, U., Powajbo, V., Korn, T., Djonov, V., Lin, J., Hammes, H., Grobholz, R., Ullrich, A., & Vajkoczy, P. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600949 · Cited by 158
Barrios, A., Poole, R. J., Durbin, L., Brennan, C. H., Holder, N., & Wilson, S. W. (2003) · Current Biology · doi:10.1016/j.cub.2003.08.030 · Cited by 154
Ting, M.-C., Wu, N. L., Roybal, P. G., Sun, J., Liu, L., Yen, Y.-H., & Maxson, R. E. (2009) · Development · doi:10.1242/dev.028605 · Cited by 152
A Human Antibody–Drug Conjugate Targeting EphA2 Inhibits Tumor GrowthIn vivo
Jackson, D., Gooya, J. M., Mao, S., Kinneer, K., XU, L. L., Camara, M., Fazenbaker, C. A., Fleming, R. L., Swamynathan, S., Meyer, D. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1933 · Cited by 151
Fukai, J., Yokote, H., Yamanaka, R., Arao, T., Nishio, K., & Itakura, T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2263 · Cited by 151
Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis
Dohn, M. R., Jiang, J., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204816 · Cited by 148
Hunter, S., Zhuang, G., Brantley‐Sieders, D. M., Swat, W., Cowan, C. W., & Chen, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02215-05 · Cited by 148
Kikawa, K. D., Vidale, D. R., Etten, R. L. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207127200 · Cited by 148
EphB4 Expression and Biological Significance in Prostate Cancer
Xia, G., Kumar, S. R., Masood, R., Zhu, S., Reddy, R., Krasnoperov, V. G., Quinn, D. I., Henshall, S. M., Sutherland, R. L., Pinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2667 · Cited by 147
Foubert, P., Silvestre, J., Souttou, B., Barateau, V., Martin, C., Ebrahimian, T. G., Déan, C., Contreres, J. O., Sulpice, E., Levy, B. I., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28338 · Cited by 146
Brantley‐Sieders, D. M., Fang, W. B., Hwang, Y., Hicks, D. J., & Chen, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1560 · Cited by 145
Wykosky, J., Palma, E., Gibo, D. M., Ringler, S. L., Turner, C. P., & Debinski, W. (2008) · Oncogene · doi:10.1038/onc.2008.328 · Cited by 144
Koolpe, M., Burgess, R., Dail, M., & Pasquale, E. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500363200 · Cited by 143
Self-citationZhuang, G., Hunter, S., Hwang, Y., & Chen, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608509200 · Cited by 142
Tatsumi, T., Herrem, C. J., Olson, W. C., Finke, J. H., Bukowski, R. M., Kinch, M. S., Ranieri, E., & Storkus, W. J. (2003) · PubMed · Cited by 139
Guo, H., Miao, H., Gerber, L., Singh, J., Denning, M. F., Gilliam, A. C., & Wang, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0004 · Cited by 139
Identification of Metastasis-Associated Receptor Tyrosine Kinases in Non–Small Cell Lung Cancer
Müller‐Tidow, C., Diederichs, S., Bulk, E., Pohle, T., Steffen, B., Schwäble, J., Plewka, S., Thomas, M., Metzger, R., Schneider, P. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3388 · Cited by 139
Preferential Induction of EphB4 over EphB2 and Its Implication in Colorectal Cancer Progression
Kumar, S. R., Scehnet, J. S., Ley, E. J., Singh, J., Krasnoperov, V. G., Liu, R., Manchanda, P. K., Ladner, R. D., Hawes, D., Weaver, F. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3232 · Cited by 138
Larsen, A. B., Pedersen, M. W., Stockhausen, M., Grandal, M. V., van Deurs, B., & Poulsen, H. S. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0321 · Cited by 137
Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors
Noberini, R., Koolpe, M., Peddibhotla, S., Dahl, R. S., Su, Y., Cosford, N. D. P., Roth, G. P., & Pasquale, E. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804103200 · Cited by 137
Self-citationSynaptic activity prompts γ-secretase–mediated cleavage of EphA4 and dendritic spine formation
Inoue, E., Deguchi‐Tawarada, M., Togawa, A., Matsui, C., Arita, K., Katahira-Tayama, S., Sato, T., Yamauchi, E., Oda, Y., & Takai, Y. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200809151 · Cited by 136
Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer
Landen, C. N., Lu, C., Han, L. Y., Coffman, K. T., Bruckheimer, E., Halder, J., Mangala, L. S., Merritt, W. M., Lin, Y. G., Gao, C., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj414 · Cited by 136
Paradoxes of the EphB4 Receptor in Cancer
Hooten, N. N., & Pasquale, E. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0525 · Cited by 132
Self-citationInhibition of Tumor Growth and Angiogenesis by Soluble EphB4
Martiny‐Baron, G., Korff, T., Schaffner, F., Esser, N., Eggstein, S., Marmé, D., & Augustin, H. G. (2004) · Neoplasia · doi:10.1593/neo.03457 · Cited by 132
Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1
Nakada, M., Drake, K. L., Nakada, S., Niska, J. A., & Berens, M. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4211 · Cited by 130
Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism
Fang, W. B., Ireton, R. C., Zhuang, G., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.017145 · Cited by 129
Parri, M., Taddei, M. L., Bianchini, F., Calorini, L., & Chiarugi, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1845 · Cited by 128
A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis
Fang, W. B., Brantley‐Sieders, D. M., Parker, M. A., Reith, A. D., & Chen, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208937 · Cited by 127
EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer
Mao, W., Luis, E., Ross, S., Silva, J., Tan, C., Crowley, C. W., Chui, C. H., Franz, G., Senter, P. D., Koeppen, H., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1047 · Cited by 127
Litterst, C. M., Georgakopoulos, A., Shioi, J., Ghersi, E., Wısnıewskı, T., Wang, R., Ludwig, A., & Robakis, N. K. R. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611449200 · Cited by 122
Furne, C., Ricard, J., Cabrera, J. R., Pays, L., Bethea, J. R., Mehlen, P., & Liebl, D. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.009 · Cited by 122
Noblitt, L. W., Bangari, D. S., Shukla, S., Knapp, D. W., Mohammed, S. I., Kinch, M. S., & Mittal, S. K. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700761 · Cited by 121
Expression of Eph receptors and ephrins is differentially regulated by E-cadherin
Oršulić, S., & Kemler, R. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.10.1793 · Cited by 119
Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract
Cooper, M. A., Son, A. I., Komlos, D., Sun, Y., Kleiman, N. J., & Zhou, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808987105 · Cited by 117
Phosphorylation of ephrin‐B1 via the interaction with claudin following cell–cell contact formation
Tanaka, M., Kamata, R., & Sakai, R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600831 · Cited by 117
Chiari, R., Hames, G., Stroobant, V., Texier, C., Maillère, B., Boon, T., & Coulie, P. G. (2000) · PubMed · Cited by 117
Fabes, J., Anderson, P. N., Brennan, C. H., & Bolsover, S. R. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05859.x · Cited by 116
Leroy, C., Fialin, C., Sirvent, A., Simon, V., Urbach, S., Poncet, J., Robert, B., Jouin, P., & Roche, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2354 · Cited by 114
Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors
Choi, Y., Syeda, F., Walker, J. R., Finerty, P. J., Cuerrier, D., Wojciechowski, A., Liu, Q., Dhe‐Paganon, S., & Gray, N. S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.029 · Cited by 112
Lin, K., Sloniowski, S., Ethell, D. W., & Ethell, I. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804401200 · Cited by 109
Eph/ephrin signaling in epithelial development and homeostasis
Miao, H., & Wang, B. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.019 · Cited by 108
Salvucci, O., Maric, D., Economopoulou, M., Sakakibara, S., Merlin, S., Follenzi, A., & Tosato, G. (2009) · Blood · doi:10.1182/blood-2008-12-192294 · Cited by 107
Downregulation of EphA7 by hypermethylation in colorectal cancer
Wang, J., Kataoka, H., Suzuki, M., Sato, N., Nakamura, R., Tao, H., Maruyama, K., Isogaki, J., Kanaoka, S., Ihara, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208720 · Cited by 107
EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility
Yamazaki, T., Masuda, J., Omori, T., Usui, R., Akiyama, H., & Maru, Y. (2008) · Journal of Cell Science · doi:10.1242/jcs.036467 · Cited by 107
Yokote, H., Fujita, K., Jing, X., Sawada, T., Liang, S., Yao, L., Yan, X., Zhang, Y., Schlessinger, J., & Sakaguchi, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509741102 · Cited by 106
Differential EphA2 epitope display on normal versus malignant cells.
Coffman, K. T., Hu, M., Carles‐Kinch, K., Tice, D. A., Donacki, N. E., Munyon, K., Kifle, G., Woods, R., Langermann, S., Kiener, P. A., et al. (2003) · PubMed · Cited by 106
Targeting the EphA4 receptor in the nervous system with biologically active peptides
Murai, K. K., Nguyen, L. N., Koolpe, M., McLennan, R., Krull, C. E., & Pasquale, E. B. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.08.006 · Cited by 106
Self-citationMenges, C. W., & McCance, D. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210957 · Cited by 103
EphrinB1 controls cell–cell junctions through the Par polarity complex
Lee, H., Nishanian, T. G., Mood, K., Bong, Y., & Daar, I. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1758 · Cited by 101
Vascular Remodeling Marks Tumors That Recur During Chronic Suppression of Angiogenesis
Huang, J., Soffer, S. Z., Kim, E. S., McCrudden, K. W., Huang, J. T., New, T. N., Manley, C. A., Middlesworth, W., O’Toole, K., Yamashiro, D. J., et al. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.36.2.1 · Cited by 101
Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors
Cheng, N., Brantley, D. M., Fang, W. B., Liu, H., Fanslow, W. C., Cerretti, D. P., Bussell, K., Reith, A. D., Jackson, D., & Chen, J. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80047-7 · Cited by 100
EphA2 as a target for ovarian cancer therapy
Landen, C. N., Kinch, M. S., & Sood, A. K. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1179 · Cited by 99
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival
Xia, G., Kumar, S. R., Stein, J. P., Singh, J., Krasnoperov, V. G., Zhu, S., Hassanieh, L., Smith, D. L., Buscarini, M., Broek, D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209108 · Cited by 98
Lafleur, K., Danzhi Huang, A., Zhou, T., Caflisch, A., & Nevado, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9009444 · Cited by 96
Miao, H., Strebhardt, K., Pasquale, E. B., Shen, T., Guan, J., & Wang, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411383200 · Cited by 95
Self-citationYang, N.-Y., Pasquale, E. B., Owen, L. B., & Ethell, I. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604338200 · Cited by 95
Self-citationRegulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway
Poliakov, A., Cotrina, M. L., Pasini, A., & Wilkinson, D. G. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200807151 · Cited by 94
Dissecting the EphA3/Ephrin-A5 Interactions Using a Novel Functional Mutagenesis Screen
Smith, F. M., Vearing, C., Lackmann, M., Treutlein, H., Himanen, J. P., Chen, K., Saul, A. J., Nikolov, D. B., & Boyd, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309326200 · Cited by 94
A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor–expressing tumor cells
Wykosky, J., Gibo, D. M., & Debinski, W. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0200 · Cited by 94
Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O
Shintani, T., Ihara, M., Sakuta, H., Takahashi, H., Watakabe, I., & Noda, M. (2006) · Nature Neuroscience · doi:10.1038/nn1697 · Cited by 92
EphrinA1-targeted nanoshells for photothermal ablation of prostate cancer cells
West, J. L. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2810 · Cited by 92
Mechanisms of Inactivation of the Receptor Tyrosine Kinase EPHB2 in Colorectal Tumors
Alazzouzi, H., Dávalos, V., Kokko, A., Domingo, E., Woerner, S. M., Wilson, A. J., Konrad, L., Laiho, P., Espín, E., Armengol, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2580 · Cited by 92
Chiu, S. T., Chang, K., Ting, C.-H., Shen, H.-C., Li, H., & Hsieh, F. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp133 · Cited by 92
Hafner, C. M., Becker, B., Landthaler, M., & VOGT, T. M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800660 · Cited by 91
EphA kinase activation regulates HGF-induced epithelial branching morphogenesis
Miao, H., Nickel, C. H., Cantley, L. G., Bruggeman, L. A., Bennardo, L. N., & Wang, B. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304018 · Cited by 90
Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647
Gendreau, S. B., Ventura, R., Keast, P., Laird, A., Yakes, F. M., Zhang, W., Bentzien, F., Cancilla, B., Lutman, J., Chu, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2590 · Cited by 90
EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma
Lee, J., Han, H. D., Shahzad, M. M. K., Kim, S. W., Mangala, L. S., Nick, A. M., Lü, C., Langley, R. R., Schmandt, R. E., Kim, H., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp231 · Cited by 90
Iida, H., Honda, M., Kawai, H. F., et al. (2005) · Gut · doi:10.1136/gut.2004.049486 · Cited by 88
Genetic Alterations in the Tyrosine Kinase Transcriptome of Human Cancer Cell Lines
Ruhe, J. E., Streit, S., Hart, S., Wong, C., Specht, K., Knyazev, P. G., Knyazeva, T., Tay, L. S., Loo, H. L., Foo, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2703 · Cited by 87
Chrencik, J., Brooun, A., Recht, M. I., Kraus, M. L., Koolpe, M., Kolatkar, A. R., Bruce, R. H., Martiny‐Baron, G., Widmer, H., Pasquale, E. B., et al. (2006) · Structure · doi:10.1016/j.str.2005.11.011 · Cited by 87
Self-citationQuantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice
Cai, W., Ebrahimnejad, A., Chen, K., Cao, Q., Li, Z., Tice, D. A., & Chen, X. S. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0503-5 · Cited by 86
Dottori, M., Down, M., Hüttmann, A., Fitzpatrick, D. R., & Boyd, A. (1999) · Blood · doi:10.1182/blood.v94.7.2477.419k13_2477_2486 · Cited by 85
Yamashita, T., Ohneda, K., Nagano, M., Miyoshi, C., Kaneko, N., Miwa, Y., Yamamoto, M., Ohneda, O., & Fujii-Kuriyama, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709133200 · Cited by 85
Wang, X.-D., Reeves, K., Luo, F., Xu, L.-A., Lee, F., Clark, E., & Huang, F. (2007) · Genome Biology · doi:10.1186/gb-2007-8-11-r255 · Cited by 85
EPHB4 and Survival of Colorectal Cancer Patients
Dávalos, V., Dopeso, H., Castaño, J., Wilson, A. J., Vilardell, F., Romero‐Giménez, J., Espín, E., Armengol, M., Capellá, G., Mariadason, J. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4640 · Cited by 85
Identification of the Jak/Stat Proteins as Novel Downstream Targets of EphA4 Signaling in Muscle
Lai, K., Chen, Y., Po, H. M., Lok, K.-C., Gong, K., & Ip, N. Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313356200 · Cited by 84
ephrinB1 signals from the cell surface to the nucleus by recruitment of STAT3
Bong, Y., Lee, H., Carim‐Todd, L., Mood, K., Nishanian, T. G., Tessarollo, L., & Daar, I. O. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702337104 · Cited by 84
Hammond, S. A., Lutterbuese, R., Roff, S. R., Lutterbuese, P., Schlereth, B., Bruckheimer, E., Kinch, M. S., Coats, S., Baeuerle, P. A., Kufer, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2760 · Cited by 82
Multiple in Vivo Tyrosine Phosphorylation Sites in EphB Receptors
Kalo, M. S., & Pasquale, E. B. (1999) · Biochemistry · doi:10.1021/bi991628t · Cited by 79
Self-citationEndothelial EphA receptor stimulation increases lung vascular permeability
Larson, J., Schomberg, S., Schroeder, W., & Carpenter, T. C. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90256.2008 · Cited by 78
Qin, H., Shi, J., Noberini, R., Pasquale, E. B., & Song, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804114200 · Cited by 77
Self-citationVearing, C., Lee, F.-T., Wimmer-Kleikamp, S. H., Spirkoska, V., To, C., Stylianou, C., Spanevello, M., Brechbiel, M. W., Boyd, A., Scott, A. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0758 · Cited by 76
Li, J.-J., Liu, D.-P., Liu, G.-T., & Xie, D. (2009) · Oncogene · doi:10.1038/onc.2009.15 · Cited by 75
Biphasic Functions of the Kinase-defective Ephb6 Receptor in Cell Adhesion and Migration
Matsuoka, H., Obama, H., Kelly, M. L., Matsui, T., & Nakamoto, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500010200 · Cited by 74
Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival
Herath, N. I., Doecke, J. D., Spanevello, M., Leggett, B., & Boyd, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604970 · Cited by 72
Eph receptors inactivate R-Ras through different mechanisms to achieve cell repulsion
Dail, M., Richter, M., Godement, P., & Pasquale, E. B. (2006) · Journal of Cell Science · doi:10.1242/jcs.02842 · Cited by 72
Self-citationPfaff, D., Héroult, M., Riedel, M., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.030627 · Cited by 70
EphA2 Engages Git1 to Suppress Arf6 Activity Modulating Epithelial Cell–Cell Contacts
Miura, K., Nam, J., Kojima, C., Mochizuki, N., & Sabe, H. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-06-0549 · Cited by 70
Regulation of Mammary Gland Branching Morphogenesis by EphA2 Receptor Tyrosine Kinase
Vaught, D., Chen, J., & Brantley‐Sieders, D. M. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0378 · Cited by 69
Kemp, H. A., Cooke, J. E., & Moens, C. B. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.12.010 · Cited by 68
Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization
Kasahara, K., Taguchi, T., Yamasaki, I., Kamada, M., Yuri, K., & Shuin, T. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00552-6 · Cited by 68
Kolb, P., Kipouros, C. B., Danzhi Huang, A., & Caflisch, A. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22028 · Cited by 68
The Eph family: a multitude of receptors that mediate cell recognition signals
Zisch, A. H., & Pasquale, E. B. (1997) · Cell and Tissue Research · doi:10.1007/s004410050926 · Cited by 67
Self-citationEphrin-independent regulation of cell substrate adhesion by the EphB4 receptor
Hooten, N. N., Yang, N.-Y., Silldorff, M. D., Mutyala, R., & Pasquale, E. B. (2009) · Biochemical Journal · doi:10.1042/bj20090014 · Cited by 65
Self-citationYamaguchi, S., Tatsumi, T., Takehara, T., Sakamori, R., Uemura, A., Mizushima, T., Ohkawa, K., Storkus, W. J., & Hayashi, N. (2007) · Cancer · doi:10.1002/cncr.22958 · Cited by 64
Chrencik, J., Brooun, A., Recht, M. I., Nicola, G., Davis, L. K., Abagyan, R. A., Widmer, H., Pasquale, E. B., & Kühn, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706340200 · Cited by 62
Self-citationECK,a HumanEPH-Related Gene, Maps to 1p36.1, a Common Region of Alteration in Human Cancers
Sulman, E. P., Tang, X. X., Allen, C., et al. (1997) · Genomics · doi:10.1006/geno.1996.4569 · Cited by 61
A Role for C. elegans Eph RTK Signaling in PTEN Regulation
Brisbin, S., Liu, J., Boudreau, J. R., Peng, J., Evangelista, M., & Chin-Sang, I. D. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.08.009 · Cited by 61
Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles
Scarberry, K. E., Dickerson, E. B., Zhang, Z. J., Benigno, B. B., & McDonald, J. F. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.11.003 · Cited by 58
Dual targeting of EphA2 and FAK in ovarian carcinoma
Shahzad, M., Lu, C.-H., Lee, J., Stone, R., Mitra, R., Mangala, L., Lu, Y.-L., Baggerly, K., Danes, C., Nick, A., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.11.8523 · Cited by 57
Winter, J., Roepcke, S., Krause, S., Müller, E., Otto, A., Vingron, M., & Schweiger, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002780 · Cited by 55
EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.
Alves, P. M. S., Faure, O., Graff‐Dubois, S., Gross, D., Cornet, S., Chouaı̈b, S., Miconnet, I., Lemonnier, F. A., & Kosmatopoulos, K. (2003) · PubMed · Cited by 55
Pei, J., Zhang, J., Sumariwalla, P. F., Ni, I., Jorgensen, B., Crawford, D., Phillips, S. L., Feldmann, M., Shepard, H. M., & Paleolog, E. M. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2447 · Cited by 53
Capillary Defects and Exaggerated Inflammatory Response in the Airways of EphA2-Deficient Mice
Okazaki, T., Ni, A., Bałuk, P., Ayeni, O. A., Kearley, J., Coyle, A. J., Humbles, A. A., & McDonald, D. M. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080949 · Cited by 51
Annamalai, B., Liu, X., Gopal, U., & Isaacs, J. S. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0582 · Cited by 51
Yumoto, N., Wakatsuki, S., Kurisaki, T., Hara, Y., Osumi, N., Frisén, J., & Sehara‐Fujisawa, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003322 · Cited by 48
Induction of cell retraction by the combined actions of Abl–CrkII and Rho–ROCK1 signaling
Huang, X., Wu, D. H., Jin, H., Stupack, D. G., & Wang, J. Y. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801192 · Cited by 47
Wu, C., Qiu, R., Wang, J., Zhang, H., Murai, K., & Lü, Q. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5841-08.2009 · Cited by 46
Bruckheimer, E. M., Fazenbaker, C. A., Gallagher, S., Mulgrew, K. A., Fuhrmann, S. R., Coffman, K. T., Walsh, W. D., Ready, S., Cook, K., Damschroder, M. M., et al. (2009) · Neoplasia · doi:10.1593/neo.81578 · Cited by 45
Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer
Oba‐Shinjo, S. M., Wang, Y., Song, J., Li, Z., Kobayashi, K., Tsugane, S., Hamada, G. S., Tanaka, M., & Sugimura, H. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00716-3 · Cited by 42
High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability
Dávalos, V., Dopeso, H., Velho, S., Ferreira, A. M., Cirnes, L., Díaz-Chico, B. N., Bilbao, C., Ramírez‐Moreno, R., Rodríguez, G., Falcón, O., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209780 · Cited by 41
Castaño, J., Dávalos, V., Schwartz, S., & Arango, D. (2008) · PubMed · doi:10.14670/hh-23.1011 · Cited by 40
Kawabe, M., Mandić, M., Taylor, J. L., Vasquez, C. A., Wesa, A. K., Neckers, L. Μ., & Storkus, W. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4511 · Cited by 39
Yang, T., Su, Y., Huang, C., Yu, J., Lo, Y., Wu, P., & Shen, C. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20080 · Cited by 34
Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors
Qiao, L., Choi, S., Case, A. W., Gainer, T. G., Seyb, K. I., Glicksman, M. A., Lo, D. C., Stein, R. L., & Cuny, G. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.010 · Cited by 33
Ephrin A5 expression promotes invasion and transformation of murine fibroblasts
Campbell, T. N., Attwell, S., Arcellana‐Panlilio, M. Y., & Robbins, S. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.085 · Cited by 30
A Novel Mechanism for p53 to Regulate Its Target Gene ECK in Signaling Apoptosis
Jin, Y. J., Wang, J., Qiao, C., Hei, T. K., Brandt‐Rauf, P. W., & Yin, Y. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0178 · Cited by 28
Wesa, A. K., Herrem, C. J., Mandić, M., Taylor, J. L., Vasquez, C. A., Kawabe, M., Tatsumi, T., Leibowitz, M. S., Finke, J. H., Bukowski, R. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7721 · Cited by 26
c‐Rel is a transcriptional repressor of EPHB2 in colorectal cancer
Fu, T., Li, P., Wang, H., He, Y., Luo, D., Zhang, A., Tong, W., Zhang, L.-Y., Liu, B., & Hu, C. (2009) · The Journal of Pathology · doi:10.1002/path.2590 · Cited by 19
Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo
van Geer, M. A., Bakker, C., Koizumi, N., Mizuguchi, H., Wesseling, J. G., Elferink, R. P. J. O., & Bosma, P. J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2754 · Cited by 18
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Chemistry and Biology Of Multicomponent Reactions
Dömling, A., Wang, W., & Wang, K. (2012) · Chemical Reviews · doi:10.1021/cr100233r · Cited by 2,547
Anoikis: an emerging hallmark in health and diseases
Taddei, M., Giannoni, E., Fiaschi, T., & Chiarugi, P. (2012) · The Journal of Pathology · doi:10.1002/path.3000 · Cited by 716
Mechanisms of ephrin–Eph signalling in development, physiology and disease
Kania, A., & Klein, R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.16 · Cited by 643
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Sawamiphak, S., Seidel, S., Essmann, C. L., Wilkinson, G. A., Pitulescu, M. E., Acker, T., & Acker-Palmer, A. (2010) · Nature · doi:10.1038/nature08995 · Cited by 534
Metadata
- Authors
- Pasquale, E. B.
- Venue
- Nature Reviews Cancer
- Published
- 2010-03
- Volume
- 10
- Issue
- 3
- Pages
- 165-180
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1997670728
- Cited by
- 1,226
- References
- 191
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.